{
    "root": "2586816e-d449-4c27-a592-44ad6a2802da",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Paroxetine",
    "value": "20250328",
    "ingredients": [
        {
            "name": "PAROXETINE HYDROCHLORIDE HEMIHYDRATE",
            "code": "X2ELS050D8"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 6000",
            "code": "30IQX730WE"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "Paroxetine tablets are indicated in adults for the treatment of:\n                  \n                     Major depressive disorder (MDD)\n                     Obsessive compulsive disorder (OCD)\n                     Panic disorder (PD)\n                     Social anxiety disorder (SAD)\n                     Generalized anxiety disorder (GAD)\n                     Posttraumatic stress disorder (PTSD)",
    "contraindications": "Recommended starting and maximum daily dosage for MDD, OCD, PD, and PTSD: ( 2.2 ) Indication Starting Dose Maximum Dose MDD 20 mg 50 mg OCD 20 mg 60 mg PD 10 mg 60 mg PTSD 20 mg 50 mg Recommended starting dosage for SAD and GAD is 20 mg daily. ( 2.3 ) Elderly patients, patients with severe renal impairment or severe hepatic impairment: Starting dosage is 10 mg daily. Maximum dosage is 40 mg daily. ( 2.4 ) When discontinuing paroxetine tablets, reduce dosage gradually. ( 2.6 , 5.7 )",
    "warningsAndPrecautions": "Paroxetine Tablets USP, 10 mg are white to off-white, round-shaped, biconvex, film-coated tablets debossed with the logo of 'ZC, 15 and bisect' on one side and plain on other side, and are supplied as follows:\n                  \n                  NDC: 71335-0544-1: 30 Tablets in a BOTTLE\n                  NDC: 71335-0544-2: 60 Tablets in a BOTTLE\n                  NDC: 71335-0544-3: 90 Tablets in a BOTTLE\n                  NDC: 71335-0544-4: 120 Tablets in a BOTTLE\n                  NDC: 71335-0544-5: 15 Tablets in a BOTTLE\n                  NDC: 71335-0544-6: 20 Tablets in a BOTTLE\n                  NDC: 71335-0544-7: 180 Tablets in a BOTTLE\n                  \n                  Store at 20째C to 25째 C (68째F to 77째 F) [See USP Controlled Room Temperature].\n                  \n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions": "Paroxetine tablets are contraindicated in patients:\n                  \n                     Taking, or within 14 days of stopping, MAOIs (including the MAOIs linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see Warnings and Precautions (5.2), Drug Interactions (7)].\n                     \n                     Taking thioridazine because of risk of QT prolongation [see Warnings and Precautions (5.3) and Drug Interactions (7)]\n                     \n                     Taking pimozide because of risk of QT prolongation [see Warnings and Precautions (5.3), Drug Interactions (7)].\n                     \n                     With known hypersensitivity (e.g., anaphylaxis, angioedema, Stevens-Johnson syndrome) to paroxetine or any of the inactive ingredients in paroxetine tablets [see Adverse Reactions (6.1), (6.2)]."
}